These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 36611858)

  • 1. Construction of a Necroptosis-Related lncRNA Signature for Predicting Prognosis and Immune Response in Kidney Renal Clear Cell Carcinoma.
    Zhang Y; Zhuang T; Xin Z; Sun C; Li D; Ma N; Wang X; Wang X
    Cells; 2022 Dec; 12(1):. PubMed ID: 36611858
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinicopathological and Prognostic Value of Necroptosis-Associated lncRNA Model in Patients with Kidney Renal Clear Cell Carcinoma.
    Gu J; He Z; Huang Y; Luan T; Chen Z; Wang J; Ding M
    Dis Markers; 2022; 2022():5204831. PubMed ID: 35664432
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel necroptosis-related long noncoding RNA model for predicting clinical features, immune characteristics, and therapeutic response in clear cell renal cell carcinoma.
    Zhang L; Chen Y; Hu W; Wu B; Ye L; Wang D; Bai T
    Front Immunol; 2023; 14():1230267. PubMed ID: 37600792
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Novel Prognostic Predictor of Immune Microenvironment and Therapeutic Response in Kidney Renal Clear Cell Carcinoma based on Necroptosis-related Gene Signature.
    Chen W; Lin W; Wu L; Xu A; Liu C; Huang P
    Int J Med Sci; 2022; 19(2):377-392. PubMed ID: 35165523
    [No Abstract]   [Full Text] [Related]  

  • 5. Establishment of a novel signature to predict prognosis and immune characteristics of pancreatic cancer based on necroptosis-related long non-coding RNA.
    Xiong Y; Kong X; Fang K; Sun G; Tu S; Wei Y; Ouyang Y; Wan R; Xiao W
    Mol Biol Rep; 2023 Sep; 50(9):7405-7419. PubMed ID: 37452900
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Construction and validation of an autophagy-related long noncoding RNA signature for prognosis prediction in kidney renal clear cell carcinoma patients.
    Yu J; Mao W; Xu B; Chen M
    Cancer Med; 2021 Apr; 10(7):2359-2369. PubMed ID: 33650306
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The clinical significance, immune infiltration, and tumor mutational burden of angiogenesis-associated lncRNAs in kidney renal clear cell carcinoma.
    Zhang W; Liu Z; Wang J; Geng B; Hou W; Zhao E; Li X
    Front Immunol; 2022; 13():934387. PubMed ID: 35958561
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel necroptosis-related lncRNA signature for predicting prognosis and anti-cancer treatment response in endometrial cancer.
    He WP; Chen YY; Wu LX; Guo YY; You ZS; Yang GF
    Front Immunol; 2022; 13():1018544. PubMed ID: 36466815
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comprehensive analysis of necroptosis-related lncRNA signature with potential implications in tumor heterogeneity and prediction of prognosis in clear cell renal cell carcinoma.
    Lin H; Qu L; Chen G; Zhang C; Lu L; Chen Y
    Eur J Med Res; 2023 Jul; 28(1):236. PubMed ID: 37452355
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gene set enrichment analysis identifies immune subtypes of kidney renal clear cell carcinoma with significantly different molecular and clinical properties.
    Chen Z; Cao W; Luo J; Abdelrahman Z; Lu Q; Wang H; Wang X
    Front Immunol; 2023; 14():1191365. PubMed ID: 37426638
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification and Validation of a Necroptosis-Related Prognostic Signature for Kidney Renal Clear Cell Carcinoma.
    Cai M; Yang Q; He J; Wu H; Li Z; Fang Z; Li J
    Stem Cells Int; 2023; 2023():8446765. PubMed ID: 36910333
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A risk signature based on necroptotic-process-related genes predicts prognosis and immune therapy response in kidney cell carcinoma.
    Li J; Liu X; Qi Y; Liu Y; Du E; Zhang Z
    Front Immunol; 2022; 13():922929. PubMed ID: 36189275
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immune associated LncRNAs identify novel prognostic subtypes of renal clear cell carcinoma.
    Khadirnaikar S; Kumar P; Pandi SN; Malik R; Dhanasekaran SM; Shukla SK
    Mol Carcinog; 2019 Apr; 58(4):544-553. PubMed ID: 30520148
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognosis Signature of Cuprotosis-Related lncRNAs Associated with Kidney Renal Clear Cell Carcinoma.
    Gao Y; Jia Z
    Genet Res (Camb); 2022; 2022():6004852. PubMed ID: 36474620
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A risk signature of necroptosis-related lncRNA to predict prognosis and probe molecular characteristics for male with bladder cancer.
    Jin Y; Li J; Tang C; He K; Shan D; Yan S; Deng G
    Medicine (Baltimore); 2023 May; 102(18):e33664. PubMed ID: 37145007
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD72, a new immune checkpoint molecule, is a novel prognostic biomarker for kidney renal clear cell carcinoma.
    Tian L; Wang Y; Zhang Z; Feng X; Xiao F; Zong M
    Eur J Med Res; 2023 Nov; 28(1):531. PubMed ID: 37980541
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comprehensive analysis of necroptosis-related long noncoding RNA to predict prognosis, immune status, and immunotherapeutic response in clear cell renal cell carcinoma.
    Tang H; Chen H; Yuan H; Jin X; Chen G
    Transl Cancer Res; 2022 Dec; 11(12):4254-4271. PubMed ID: 36644185
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comprehensive prognostic and immunological analysis of telomere-related lncRNAs in kidney renal clear cell carcinoma.
    Chen J; Zhang D; Ren X; Wang P
    Aging (Albany NY); 2023 Oct; 15(20):11012-11032. PubMed ID: 37847171
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Disulfidptosis-Related LncRNA Signatures for Prognostic Prediction in Kidney Renal Clear Cell Carcinoma.
    Feng K; Zhou S; Sheng Y; Lu K; Li C; Liu W; Kong H; Liu H; Mu Y; Zhang L; Zhang Q; Wang J
    Clin Genitourin Cancer; 2024 Aug; 22(4):102095. PubMed ID: 38833825
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Disulfidptosis-associated LncRNA signature predicts prognosis and immune response in kidney renal clear cell carcinoma.
    Xu K; Li D; Ji K; Zhang Y; Zhang M; Zhou H; Hou X; Jiang J; Zhang Z; Dai H; Sun H
    Biol Direct; 2024 Aug; 19(1):71. PubMed ID: 39175011
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.